Objectives. Preparation of intravenous solution in advance could be efficient to improve quality assurance, security, time management, and cost saving of drug delivery. The purpose of this study was to investigate the stability of a mixture of tramadol chlorhydrate and metoclopramide hydrochloride in dextrose 5% polyolefin bags at 4°C.
Methods. The stability of five bags of solution containing 100 mg tramadol and 10 mg metoclopramide per 100 mL dextrose 5% and stored at 4°C was studied during 32 days and concentrations measured by high performance liquid chromatography-diode array detection.
Results. No degradation interference nor modification in retention times were observed throughout the study period. At day 32, tramadol concentration was 96.9% ± 2.1 and metoclopramide 97.2% ± 1.3 of the initial concentration.
Conclusion. Based on a shelf-life of 90% residual potency, tramadol and metoclopramide were compatible and stable for at least 32 days at 4°C and can be prepared in advance in a centralized intravenous additive service facility. J Oncol Pharm Practice (2009) 15: 195—200.
Fallon M., Hanks G., Cherny N.Principles of control of cancer pain. BMJ2006; 332: 1022-24.
2.
World Health Organization. Cancer pain relief and palliative care. WHO Technical Report Series 804, Geneva, 1990.
3.
Lehman KATramadol for the management of acute pain. Drugs1994; 47: 19-32.
4.
Leppert W., Luczak J.The role of tramadol in cancer pain treatment-a review. Support Care Cancer2005; 13: 5-17.
5.
Lee CR, Mc Tavish D., Sorkin EMTramadol. A preliminary review of its pharmaodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain. Drugs1993; 46: 313-40.
6.
Houmes R., Voets M., Verkaaik A., Erdmann W., Lachmann B.Efficacy and safety of tramadol versus morphine for moderate and severe postoperative pain with special regard to respiratory depression. Anesth Analg1992; 74: 510-14.
7.
Grond S., Radbruch L., Meuser T., Loick G., Sabatowski R., Lehmann K.High-dose tramadol in comparison to low-dose morphine for cancer pain relief . J Pain Symptom Manage1999; 18: 174-79.
8.
Vickers M., O’Flaherty D., Szekely SM, Read M., Yoshizumi J.Tramadol: pain relief by an opioid without depression of respiration. Anaesthesia1992; 47: 291-96.
9.
Cossmann M., Kohnen C., Langford R., McCartney C.Tolérance et sécurité d’emploi du tramadol. Résultats des études internationales et données de la pharmacovigilance . Drugs1997; 53(suppl 2): 50-62.
10.
Nossol S., Schwarzbold M., Stadler T.Treatment of pain with sustained-release tramadol 100, 150, 200 mg: results of a post-marketing surveillance study. Int J Clin Pract1998; 52: 115-21.
11.
Cicero J., Adams E., Geller A., Inciardi J., Munoz A., Schnoll S. et al. A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States. Drug Alcohol Depend1999; 57: 7-22.
12.
Lelli G., Montanari M., Gilli G., Scapoli D., Antonietti C.Treatment of the cancer anorexia-cachexia syndrome: a critical reappraisal . J Chemother2003; 15: 220-25.
13.
Strasser F. , Bruera E.Update on anorexia and cachexia. Hematol Oncol Clin North Am2002; 16: 589-617.
14.
Davis M., Walsh D.Treatment of nausea and vomiting in advanced cancer. Support Care Cancer2000; 8: 444-52.
15.
Spaulding M.Recent studies of anorexia and appetite stimulation in the cancer patient. Oncology1989; 3(suppl.): 17-23.
16.
Tortorice P. , O’Connell M.Management of chemotherapy-induced nausea and vomiting. Pharmacotherapy1990; 10: 129-45.
17.
Blijham G.Prevention and treatment of organ toxicity during high-dose chemotherapy: an overview. Anticancer Drugs1993; 4: 527-33.
18.
Pang WW, Wu HS, Lin CH, Chang DP, Huang MHMetoclopramide decreases emesis but increases sedation in tramadol patient-controlled analgesia. Can J Anaesth2002; 49: 1009-15.
19.
Majedi H., Rabiee M., Khan ZH, Hassannasab B.A comparison of metoclopramide and lidocaine for preventing pain on injection of diazepam. Anesth Analg2002; 95: 1297-99.
Muller HJ, Berg J.Stability of tramadol HCl in pvc infusion bags. Krankenhauspharmazie1997; 18: 75-79.
22.
Von Bettina L., Brune K.Metamizol in infusionslösung. Krankenhauspharmazie1993; 14: 157-61.
23.
Abanmy MO, Zaghloul IZ, Radwan MACompatibility of tramadol HCl injection with selected drugs and solutions . Am J Health-Syst Pharm2005; 62: 1299-1302.
24.
Negro S., Martin A., Azuara ML, Sanchez Y., Barcia E.Stability of tramadol and haloperidol for continuous subcutaneous infusion at home. J Pain Symptom Manage2005; 30: 192-99.
25.
Barcia E., Martin A., Azuara M., Sanchez Y., Negro S.Tramadol and hyoscine N-butyl bromide combined in infusion solutions: compatibility and stability. Support Care Center2006; 15: 57-62.
26.
Negro S., Azuara ML, Sanchez Y., Reyes R., Barcia E.Physical compatibility and in vivo evaluation of drug mixtures for subcutaneous infusion to cancer patients in palliative care. Support Care Center2002; 10: 65-70.
27.
Kleinberg ML , Chang P.Overfill of common piggybag admixture solutions . Hosp Pharm1984; 19: 657-58.
28.
Lebrun J., Hecq JD, Vanbeckbergen D., Jamart J., Galanti L.Effect of freezing, long-term storage and microwave thawing on stability of tramadol in 5% dextrose infusion polyvinyl chloride bags. Int J Pharm Compound2004; 8: 156-59.
29.
Ruberg SJ, Stegeman JWPooling data for stability studies: testing the equality of batch degradation slopes. Biometrics1991; 47: 1059-69.
30.
Guideline for submitting documentation for the stability of human drugs and biologics. Rockville, MD: Food and Drug administration, 1987. Available at: www.fda.gov/ohrms/dockets/dockets/05d0047/05d-0047-bkg0001-Tab-08.pdf (accessed February 28, 2007).
31.
Koundalijan J.Setting up a CIVAS. In: Needle R, Sizer T, eds. The CIVAS handbook, first edition. London: Pharmaceutical Press, 1998: 1-5.
32.
Galanti LM, Hecq JD, Vanbeckbergen D., Jamart J.Long-term stability of cefuroxime and cefazolin sodium in intravenous solutions . J Clin Pharm Ther1996; 21: 185-89.
33.
Galanti LM, Hecq JD, Vanbeckbergen D., Jamart J.Assessement of the stability of teicoplanin in intravenous solutions. Int J Pharmaceut Compound2001; 5: 397-400.
34.
Boitquin LP, Hecq JD, Vanbeckbergen D., Jamart J., Galanti LMStability of sulfentanil citrate with levobupivacaine HCl in NaCl 0.9% infusion after microwave freeze-thaw treatment. Ann Pharmacother2004; 38: 1836-39.
35.
Hecq JD, Berlage V., Vanbeckbergen D., Jamart J., Galanti LMEffects of freezing, long-term storage, and microwave thawing on the stability of Piperacillin plus Tazobactam 5% in 5% dextrose for infusion. Can J Hosp Pharm2004; 57: 276-82.
36.
Trissel LAThe new national standard for sterile preparation. Hosp. Pharm2004; 39: 900-04.
